CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TIRmed pharma AB has developed TIR-C, a non-steroid cream designed to relieve itch in Atopic Dermatitis (AD). This innovative treatment targets mild-to-moderate symptoms in children, offering a safe and affordable alternative to biologics, with the potential to improve quality of life for AD sufferers.
TIRmed pharma AB has developed a non-steroid cream that relives itch in Atopic Dermatitis (AD).
Itch is an enormous, unresolved symptom in AD, induced by inflammation and skin damage. AD poses a significant burden on societies and patients’ quality of life due to itch, infected lesions, sleep deprivation, and consequently productivity loss, psychological health and treatment-associated expenditures.
Persons affected by AD consistently rate AD management to be comparable to diabetes management. O…
TIRMED PHARMA AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
